Promoter Dr. Harin Kanani has pledged 13,19,083 equity shares of Neogen Chemicals as of March 30, 2026. The disclosure confirms this was the sole instance of encumbrance creation by the promoter group during the financial year ended March 31, 2026.

Haridas Thakarshi Kanani, a promoter of Neogen Chemicals, submitted the declaration to the stock exchanges under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing explicitly states that apart from the pledge by Dr. Harin Kanani, there was no creation, invocation, or release of encumbrance on any shares held by the promoter or persons acting in concert during FY26.

The disclosure was addressed to BSE Limited and National Stock Exchange of India Limited. Copies of the submission were forwarded to the Audit Committee and Unnati Kanani, the Company Secretary and Compliance Officer of Neogen Chemicals.

Key Disclosure Details

Neogen Chemicals Limited management will participate in an analyst and investor group meeting on June 23, 2026, to discuss its business overview, financial performance, and outlook. The meeting, titled India Inc. Unplugged by PhillipCapital - Private Client Group, is scheduled to take place at Grand Hyatt, Mumbai. The session will feature a mix of 1x1 and group meetings, providing a platform for engagement with the investment community.

The participation is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has clarified that no unpublished price sensitive information will be shared during the meeting. Additionally, the company noted that the date and participants of the meet are subject to change due to exigencies on the part of organizers, investors, analysts, or the company.

Further details regarding the meeting have been uploaded on the company’s website. The intimation was submitted by Unnati Kanani, Company Secretary & Compliance Officer of Neogen Chemicals Limited.